Euro
USD
British Pound
NULL
Product Description
RTA-402 is a synthetic triterpenoid compound with anti-inflammatory, antitumor and cytoprotective properties. RTA-402 is a potent nuclear factor erythroid 2-related factor 2 (Nrf2) activator. CDDO-Me has been used for the treatment of chronic kidney disease, cancer (including leukemia and solid tumors), and other diseases.
RTA-402 is a synthetic triterpenoid compound with anti-inflammatory, antitumor and cytoprotective properties. RTA-402 is a potent nuclear factor erythroid 2-related factor 2 (Nrf2) activator. CDDO-Me has been used for the treatment of chronic kidney disease, cancer (including leukemia and solid tumors), and other diseases.
Biovision | B1974 | RTA-402 DataSheet
Alternate Name/Synonyms: Bardoxolone methyl; CDDO Methyl ester; CDDOMe; NSC 713200; RTA402
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 218600-53-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₃₂H₄₃NO₄
Molecular Weight: 505.69
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (~ 5 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent nuclear factor erythroid 2-related factor 2 (Nrf2) activator
MDL Number: MFCD11983137
PubChem CID: 400769
SMILES: CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C
InChi: InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1
InChi Key: WPTTVJLTNAWYAO-KPOXMGGZSA-N
